09548

Cyber Savings Season: Get 30% off ACS membership with promo code CYBER24. Offer valid though Dec. 11.

Already an ACS Member? Log in here

Basic

$0 Community Associate

ACS’s Basic Package keeps you connected with C&EN and ACS.

JOIN NOW

Standard

$80 Regular Members & Society Affiliates

ACS’s Standard Package lets you stay up to date with C&EN, stay active in ACS, and save.

Eligibility restrictions apply. Review ACS Membership Packages to see if you qualify.

JOIN NOW

Premium

$160 Regular Members & Society Affiliates
$55 Graduate Students
$25 Undergraduate Students

ACS’s Premium Package gives you full access to C&EN and everything the ACS Community has to offer.

ACS offers discounts for some countries outside the United States. This discount is shown at checkout, if applicable.

JOIN NOW

« Prev

December 4, 2017 Cover

Volume 95, Issue 48

Trump’s tweets, therapeutic T cells, and a turning point for gene therapy were just a few topics that made headlines in 2017

Cover image:

Credit:

Full Article

Volume 95 | Issue 48

« Prev

Trump’s tweets, therapeutic T cells, and a turning point for gene therapy were just a few topics that made headlines in 2017

EPA embraces new era in risk assessment

Caltech and Stanford plan to drop ABET to modernize their curricula and offer students more flexibility, but others still see value in the standards

People

How a German journal became a top-tier, international publication

Peter Gölitz looks back on his career as editor in chief of Angewandte Chemie
Business

DuPont takes a crack at running a chemistry incubator

Legendary Experimental Station now hosts an effort to bring in outsider technology and foster an entrepreneurial spirit
Business

Toray admits subsidiary faked data

Giant materials supplier is the latest caught falsifying quality controls
Sign up for C&EN must-read weekly newsletter

Email Address*

Contact us to opt out anytime